Glaukos Corp
NYSE:GKOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Glaukos Corp
NYSE:GKOS
|
US |
|
Royalty Pharma PLC
NASDAQ:RPRX
|
US |
|
N
|
National Storage Affiliates Trust
F:4GC
|
US |
|
BTC Digital Ltd
NASDAQ:BTCT
|
CN |
|
G
|
Galaxy Digital Holdings Ltd
OTC:BRPHF
|
US |
|
F
|
Frontline Plc
OSE:FRO
|
CY |
|
SSAB AB
OTC:SSAAY
|
SE |
|
Tata Capital Ltd
NSE:TATACAP
|
IN |
|
Dingdong (Cayman) Ltd
NYSE:DDL
|
CN |
|
E
|
Eiffage SA
OTC:EFGSY
|
FR |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
Schneider Electric SE
PAR:SU
|
FR |
|
Predictive Oncology Inc
NASDAQ:POAI
|
US |
|
Ebusco Holding NV
AEX:EBUS
|
NL |
|
Computer Age Management Services Ltd
NSE:CAMS
|
IN |
|
I
|
Immutep Ltd
NASDAQ:IMMP
|
AU |
|
B
|
Booking Holdings Inc
XBER:PCE1
|
US |
Wall St Price Targets
GKOS Price Targets Summary
Glaukos Corp
According to Wall Street analysts, the average 1-year price target for GKOS is 158.44 USD with a low forecast of 137.36 USD and a high forecast of 178.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GKOS's stock price target?
Price Target
158.44
USD
According to Wall Street analysts, the average 1-year price target for GKOS is 158.44 USD with a low forecast of 137.36 USD and a high forecast of 178.5 USD.
What is the Revenue forecast for Glaukos Corp?
Projected CAGR
27%
Over the last 12 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 3 years is 27%.
What is the Gross Profit forecast for Glaukos Corp?
Projected CAGR
31%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 3 years is 31%.
